Rekah Pharmaceutical Prod Ltd

XTAE:REKA (Israel)  
₪ 13.11 (-4.1%) Apr 25
At Loss
P/B:
0.94
Market Cap:
₪ 149.65M ($ 39.09M)
Enterprise V:
₪ 313.95M ($ 82.02M)
Volume:
926.00
Avg Vol (2M):
2.47K
Volume:
926.00
At Loss

Business Description

Description
Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset 0.32
Debt-to-Equity 1.18
Debt-to-EBITDA 5.89
Interest Coverage 0.65
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.25
Distress
Grey
Safe
Beneish M-Score -2.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.09
9-Day RSI 40.23
14-Day RSI 41.68
6-1 Month Momentum % -16.45
12-1 Month Momentum % -14.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.75
Quick Ratio 1.08
Cash Ratio 0.13
Days Inventory 141.08
Days Sales Outstanding 138.59
Days Payable 131.68

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -7.49